Angiodynamics Stock – Fundamental Analysis

Price
11.05
10/14/2026
May 2004
Oct 2026

Fundamental Data & Ratios (Balance sheet update: 7/17/2026)

Balance Sheet Total Assets 267,163,000.00 ROE 63.94 %
Balance Sheet Total Equity 170,825,000.00 ROA -13.75 %
Cashflow Capital Expenditures -2,581,000.00 P/FCF 903.27
Cashflow Free Cash Flow 508,000.00 – –
Cashflow Operating Cash Flow 3,089,000.00 P/CF 148.55
Income Earnings per Share (diluted) -0.88 Div. Yield –
Income Net Income -36,742,000.00 P/E -12.56
Income Shares Outstanding 41,526,000.00 P/B 2.69
Income Total Revenue 320,174,000.00 P/S 1.43

Ratios calculated on: 10/14/2026

Company Description

AngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company's devices are used in minimally invasive, image-guided procedures. The Company offers products within three product groupings: Peripheral Vascular, Vascular Access and Oncology/Surgery. The Company's Peripheral Vascular products include Fluid Management, Venous, Thrombus Management, as well as other core products. The Company's BioFlo products incorporate Endexo Technology into the manufacturing and design of its Vascular Access products. Its Oncology/Surgery product offerings include its Microwave Ablation products, Radiofrequency Ablation (RFA) and its NanoKnife product lines.

Advanced Analysis Features

Additional comparison and history views are available after login.

Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.angiodynamics.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown. Learn more